XML 33 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
Share-Based Compensation
The Company accounts for share-based compensation in accordance with ASC Topic 718. Share-based compensation cost is recognized over the requisite service period. Compensation cost for awards with graded vesting is recognized using the accelerated attribution method. Share-based compensation cost is reflected as a component of general and administrative expenses. A detail of share-based compensation cost for the years ended December 31, 2017, 2016 and 2015 is as follows (in thousands):
 
 
Year Ended December 31,
 
 
2017
 
2016
 
2015
Stock options:
 
 
 
 
 
 
Incentive Stock Options (share settled)
 
$
820

 
$
206

 
$
243

Non-Qualified Stock Options (share settled)
 
387

 
164

 
71

Restricted stock (share settled)
 
197

 
1,073

 
4,303

Cash settled stock units
 
245

 
244

 
(439
)
Share-based compensation
 
$
1,649

 
$
1,687

 
$
4,178

During each of the years ended December 31, 2017 and 2016, the Company capitalized $0.1 million of compensation cost related to cash settled restricted stock units to oil and gas properties. No such amounts were capitalized during the year ended December 31, 2015. During the years ended December 31, 2017, 2016 and 2015, the Company recorded income tax benefits of approximately $0.3 million, $0.5 million and $1.5 million, respectively, related to share-based compensation expense recognized during those periods. As a result of the Company’s net operating loss position, no excess tax benefits have been recognized for any periods presented.
Share-Based compensation settled in shares
At December 31, 2017, the Company had $3.9 million of unrecognized compensation cost related to unvested restricted stock and stock options. This amount will be recognized as compensation expense over a weighted average period of approximately three years.
Stock Options
Stock options may be granted to employees and consultants and generally vest ratably over a three-year period. Stock options may also be granted to directors and generally vest one year or less from the date of grant to align with their term on the board. Stock options must be exercised within 10 years of the grant date. The exercise price of each option may not be less than the fair market value of a share of common stock on the date of grant. Upon a change in control of the Company, all outstanding options become immediately exercisable.
The Company computes the fair value of its stock options using the Black-Scholes option-pricing model assuming an expected term based on historical activity and expected volatility computed using historical stock price fluctuations on a weekly basis for a period of time equal to the expected term of the option. Periodically, the Company adjusts compensation expense based on the difference between actual and estimated forfeitures.    
There were no stock options granted in 2015. The following table outlines the assumptions used in computing the fair value of stock options granted during 2017 and 2016:    
 
Years Ended December 31,
 
2017
 
2016
Dividend yield
—%
 
—%
Expected volatility
80.44%
 
62.0%-79.99%
Risk-free rate
1.925%
 
1.255%-2.09%
Expected term
6 years
 
6 years
Stock options granted
219,130
 
1,168,754
Wgtd. avg. grant date fair value per share
$1.28
 
$1.96
Fair value of grants
$280,000
 
$2,293,000

     The following table details stock option activity during the year ended December 31, 2017:
 
 
Number of
Options
 
Wgtd. Avg.
Exercise  Price
 
Wgtd. Avg.
Remaining  Life
 
Aggregate
Intrinsic  Value
(000’s)
Outstanding at beginning of year
 
1,412,940

 
$
7.13

 
 
 
 
Granted
 
219,130

 
1.85

 
 
 
 
Expired/cancelled/forfeited
 
(23,424
)
 
21.49

 
 
 
 
Exercised
 

 


 
 
 
 
Outstanding at end of year
 
1,608,646

 
6.20

 
8.08
 
$
9

 
 
 
 
 
 
 
 
 
Options exercisable at end of year
 
705,594

 
$
10.34

 
7.00
 
$

Options expected to vest
 
1,563,493

 
6.29

 
8.06
 
$
8


The total fair value of stock options that vested during the years ended December 31, 2017, 2016 and 2015 was $1.6 million, $0.4 million and $0.8 million, respectively. The intrinsic value of stock options exercised was immaterial for all periods presented.
The following table summarizes information regarding stock options outstanding at December 31, 2017:
 
 
 
 
 
 
 
 
 
 
 
Range of
 
Options
 
Wgtd. Avg.
 
Wgtd. Avg.
 
Options
 
Wgtd. Avg.
Exercise
 
Outstanding
 
Remaining
 
Exercise
 
Exercisable
 
Exercise
Price
 
12/31/2017
 
Contractual Life
 
Price
 
12/31/2017
 
Price
$0.00-$2.49
 
285,503

 
9.48
 
$1.97
 
22,150

 
$2.37
$2.50-$3.49
 
878,833

 
8.74
 
$3.17
 
362,973

 
$3.17
$3.50-$4.99
 
206,769

 
8.38
 
$4.26
 
82,930

 
$4.23
$15.00-$30.32
 
237,541

 
3.71
 
$24.18
 
237,541

 
$24.18
 
 
1,608,646

 
 
 
 
 
705,594

 
$10.34

Restricted Stock
The Company computes the fair value of its service based restricted stock using the closing price of the Company’s stock at the date of grant. Restricted stock granted to employees generally vests ratably over a three-year period. Restricted stock granted to directors vests one year or less from the date of grant to align with their term on the board. Upon a change in control of the Company, all outstanding shares of restricted stock will become immediately vested.
The following table details restricted stock activity during the year ended December 31, 2017:
 
 

Number of
Shares
 
Wgtd. Avg.
Fair Value  per
Share
Outstanding at beginning of year
 
78,557

 
$16.57
Granted
 
487,502

 
$1.87
Lapse of restrictions
 
(78,557
)
 
$16.57
Outstanding at December 31, 2017
 
487,502

 
$1.87

The weighted average grant date fair value of restricted stock granted during the years ended December 31, 2017 and 2015 was $1.87 and $5.08, respectively, per share. No restricted stock was granted in 2016. The total fair value of restricted stock that vested during the years ended December 31, 2017, 2016 and 2015 was $1.3 million, $2.4 million and $4.7 million, respectively.
Share-Based compensation settled in cash
Restricted Stock Units
The Company may grant restricted stock units ("RSUs") to employees that vest ratably over a three-year period. Cash payment will be made to employees on each vesting date based upon the Company's closing stock price on that date. Upon change in control of the Company, all of the RSUs will immediately vest. The Company computes the fair value of the RSUs using the closing price of the Company's stock at the end of each period and records a liability based on the percentage of requisite service rendered at the reporting date. During 2017 and 2016, the Company paid $0.1 million and $0.3 million, respectively, to settle 31,703 and 111,461 RSUs, respectively, that vested during the period.
Market Based Restricted Stock Units
The Company granted 60,767 market based restricted stock units ("MRSUs") to executive officers during November 2014. The executive officers can earn between 0-200% of the MRSUs granted based on the Company's performance versus a defined peer group. The 2014 MRSUs vest in one-third increments on each of the first, second and third annual anniversaries starting January 1, 2016. Upon change in control of the Company, all of the MRSUs will immediately vest. The number of MRSUs that ultimately vest is based on the Company's total shareholder return in the last 20 days of the fiscal year in relation to the last 20 days of the previous fiscal year in comparison to a group of 12 selected peer stocks of similar sized companies which operate within the same sector. The performance period ended on December 31, 2015 and executive officers earned 50% of the MRSUs. The MRSUs are cash settled on each vesting date based on the number of MRSUs that vest multiplied by the Company's closing stock price. In November 2017, the Company granted an additional 270,269 MRSUs. The performance period is scheduled to end on December 31, 2018 for these grants. The Company estimates the fair value of the outstanding MRSUs using a Monte Carlo valuation model and records a liability based on the percentage of requisite service rendered at the reporting date. The Monte Carlo valuation model considers such inputs as the stock prices of the Company and its peer group, a risk-free interest rate, and an estimated volatility for the Company and its peer group. As of December 31, 2017 and December 31, 2016, the Company had a liability for RSUs and MRSUs outstanding in the amount of $0.3 million and $0.1 million, respectively, based upon the closing stock price at December 31, 2017 and December 31, 2016.
The following table details MRSU and RSU activity during the year ended December 31, 2017:
 
MRSU
RSU
Total
Outstanding at beginning of year
14,929

31,979

46,908

Granted
270,269

889,587

1,159,856

Expired/Cancelled/Forfeited

(276
)
(276
)
Vested/Paid
(7,465
)
(31,703
)
(39,168
)
Outstanding at December 31, 2017
277,733

889,587

1,167,320